Clinical Trial Update: Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication) [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating the safety and efficacy of Propionyl-L-Carnitine for Peripheral Arterial Disease presenting with intermittent claudication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Arterial Disease

Drugs mentioned

• Propionyl-L-Carnitine (Propionyl-L-Carnitine)

Snippet

Sponsor: Sigma-Tau Research, Inc. | Conditions: Peripheral Vascular Diseases, Intermittent Claudication | Phase 3 | Status: COMPLETED